Medicure Inc.'s MC-1 Does Not Appear To Reduce Risk Of Heart Attack Or Death Following CABG Surgery

EurekAlert -- Use of MC-1 (a naturally occurring metabolite of vitamin B6) before and for 30 days after coronary artery bypass graft surgery did not reduce the risk of heart attack or cardiovascular death, according to a JAMA study being released early online April 1 to coincide with its presentation at the annual conference of the American College of Cardiology. The study will be published in the April 16 issue of JAMA.

Back to news